Boston Scientific target price cut to $51 from $57
BSX•Truist Securities cut its target price for Boston Scientific to $51 from $57.
Related News
Amplitude schedules Q3 2026 earnings webcast
AMPL•
Franklin Electric schedules third-quarter 2026 earnings release, conference call
FELE•
Deutsche Bank sees European scale-ups gaining momentum as venture capital rises 44% in Germany
DB•
Tempest Therapeutics appoints John W. Frederick to board of directors
TPST•
National Fuel Gas rises after unveiling upstream business spin-off plan
NFG•